as on October 16, 2025 at 1:10 pm IST
Day's Low
Day's High
2.03%
Downside
2.97%
Upside
52 Week's Low
52 Week's High
38.49%
Downside
25.75%
Upside
as on October 16, 2025 at 1:10 pm IST
Market Cap
₹2,444.85 Cr
Return on Equity (ROE)
11
PE Ratio (TTM)
32.33
Return on capital employed (ROCE)
12.18
Industry PE ratio
41.6
Beta (LTM)
1.44
P/B Ratio
2.87
Dividend Yield
0.19
PEG Ratio
18.06
Quarterly Earnings Growth YOY
14.29
EPS (TTM)
7.6
Sector
Pharmaceuticals
Book Value
70.36
Technical Analysis
Bullish
View Technical Analysis
as on October 16, 2025 at 1:10 pm IST
Sms Pharma in the last 5 years
Lowest (-163.97x)
June 20, 2023
Today (32.33x)
October 15, 2025
Industry (41.60x)
October 15, 2025
Highest (2093.00x)
November 11, 2022
Today’s Price to Earnings Ratio: 32.33x
Compare market cap, revenue, PE, and other key metrics of Sms Pharma with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 2,444.85 | 42.93% | 0.66 | 67 | 782 | |
NA | 37.10 | -6.21% | 0.82 | 3 | 168 | |
NA | 22.33 | 3.27% | 0.00 | -2 | 24 | |
NA | 253.27 | 13.3% | 0.63 | 4 | 196 | |
NA | 308.63 | 6.62% | 0.00 | NA | NA |
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Sms Pharma.
SMS Pharmaceuticals Ltd’s net profit jumped 24.33% since last year same period to ₹20.49Cr in the Q1 2025-2026. On a quarterly growth basis, SMS Pharmaceuticals Ltd has generated 0.84% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, SMS Pharmaceuticals Ltd has declared dividend of ₹0.40 per share on 30 May 2025 - translating a dividend yield of 0.15%.
Read More about DividendsCheck stock indices that include Sms Pharma.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 4 quarters, 14.1 Cr → 20.49 Cr (in ₹), with an average increase of 11.3% per quarter
Promoter Holding Up
Promoters have increased holdings from 66.26% to 68.07% in Sep 2025 quarter
FII Holding Up
Foreign Institutions have increased holdings from 0.03% to 0.17% in Sep 2025 quarter
Best in 3 Years
In the last 3 years, SMSPHARMA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Price Rise
In the last 3 months, SMSPHARMA stock has moved up by 12.4%
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 7.3% return, outperforming this stock by 27.8%
MF Holding Down
Mutual Funds have decreased holdings from 3.03% to 2.88% in Sep 2025 quarter
Revenue Fall
Revenue is down for the last 2 quarters, 249.62 Cr → 196.64 Cr (in ₹), with an average decrease of 21.2% per quarter
Retail Holding Down
Retail Investor have decreased holdings from 30.67% to 28.89% in Sep 2025 quarter
Organisation | SMS Pharmaceuticals Ltd |
Headquarters | Hyderabad |
Industry | Pharmaceuticals |
CEO | P Ramesh Babu |
E-voting on shares | Click here to vote |
Sms Pharma share price today stands at ₹286.2 as on . Sms Pharma share today touched a day high of ₹294.7 and a low of ₹280.4.
Sms Pharma touched a 52 week high of ₹359.9 and a 52 week low of ₹176.05. Sms Pharma share price today i.e. is trending at ₹286.2, which is -20.48% down from its 52 week high and 62.57% up from its 52 week low.
Sms Pharma market capitalisation is ₹2,444.85 Cr as on .
To buy Sms Pharma shares, you need to follow these steps:
Sms Pharma trading volume is 6.35L as on . This means that 6.35L shares of Sms Pharma were bought and sold on the stock market during today's trading session.